I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| astrocyte | 10 studies | 40% ± 12% | |
| oligodendrocyte | 9 studies | 41% ± 10% | |
| endothelial cell | 8 studies | 26% ± 6% | |
| microglial cell | 7 studies | 39% ± 6% | |
| ciliated cell | 6 studies | 35% ± 17% | |
| natural killer cell | 6 studies | 19% ± 4% | |
| CD8-positive, alpha-beta T cell | 6 studies | 19% ± 2% | |
| classical monocyte | 5 studies | 18% ± 4% | |
| plasmacytoid dendritic cell | 5 studies | 20% ± 3% | |
| epithelial cell | 5 studies | 40% ± 24% | |
| non-classical monocyte | 4 studies | 19% ± 4% | |
| GABAergic neuron | 4 studies | 22% ± 3% | |
| Mueller cell | 4 studies | 21% ± 3% | |
| oligodendrocyte precursor cell | 4 studies | 18% ± 2% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 21% ± 3% | |
| CD4-positive, alpha-beta T cell | 3 studies | 18% ± 0% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 18% ± 1% | |
| myeloid cell | 3 studies | 19% ± 3% | |
| lymphocyte | 3 studies | 24% ± 6% | |
| glutamatergic neuron | 3 studies | 22% ± 3% | |
| gamma-delta T cell | 3 studies | 18% ± 2% |
